BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 29882421)

  • 1. Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach.
    Giovannini A; Parravano M; Ricci F; Bandello F
    Eur J Ophthalmol; 2019 Jan; 29(1):82-91. PubMed ID: 29882421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach.
    García Layana A; Adán A; Ascaso FJ; Cabrera F; Donate J; Escobar Barranco JJ; Peralta G; Reyes García R; Rodríguez Maqueda M; Ruiz-Moreno JM; Vinagre I;
    Eur J Ophthalmol; 2020 Sep; 30(5):1042-1052. PubMed ID: 31291782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of anatomical biomarkers in subtypes of diabetic macular edema refractory to anti-vascular endothelial growth factor treated with dexamethasone implant.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Hernández-Bel L; Monferrer-Adsuara C; Mata-Moret L; Montero-Hernández J
    Eur J Ophthalmol; 2020 Jul; 30(4):764-769. PubMed ID: 30832509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU; Harless A; Bleau L; Maturi RK
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA.
    Zhioua I; Semoun O; Lalloum F; Souied EH
    Retina; 2015 Jul; 35(7):1429-35. PubMed ID: 26102440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the management of diabetic macular oedema with intravitreal dexamethasone implant: A national Delphi consensus study.
    Kodjikian L; Baillif S; Couturier A; Creuzot-Garcher C; Delyfer MN; Matonti F; Weber M
    Eur J Ophthalmol; 2022 Sep; 32(5):2845-2856. PubMed ID: 34779302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early versus late switch: How long should we extend the anti-vascular endothelial growth factor therapy in unresponsive diabetic macular edema patients?
    Hernández Martínez A; Pereira Delgado E; Silva Silva G; Castellanos Mateos L; Lorente Pascual J; Lainez Villa J; García Vicente P; Almeida-González CV
    Eur J Ophthalmol; 2020 Sep; 30(5):1091-1098. PubMed ID: 31096782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
    BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
    Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z
    Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expert recommendations for the management of diabetic macular edema with intravitreal dexamethasone implant: A Turkish Delphi study.
    Batıoğlu F; Yanık Ö; Saatçi AO; Eldem B; Akkın C; Afrashi F; Özdemir H; Menteş J; Güngör K; Karabaş L; Karaçorlu M; Demircan N; Koçak N; Kır N; Ünlü N; Avcı R; Arvas S; Dündar SO; Kadayıfçılar S; Kaynak S; Özdek Ş; Ovalı T
    Eur J Ophthalmol; 2023 Jan; 33(1):398-407. PubMed ID: 35924358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
    Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H
    BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of diabetic macular edema patients in clinical practice in Spain.
    Abreu-Gonzalez R; Gallego-Pinazo R; Abraldes M; Pinilla I; Lopez-Galvez MI
    Eur J Ophthalmol; 2019 Nov; 29(6):664-672. PubMed ID: 30295076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone implant for the treatment of persistent diabetic macular oedema despite long-term treatment with bevacizumab.
    Joe AW; Wickremasinghe SS; Gillies MC; Nguyen V; Lim LL; Mehta H; Fraser-Bell S
    Clin Exp Ophthalmol; 2019 Mar; 47(2):287-289. PubMed ID: 30084193
    [No Abstract]   [Full Text] [Related]  

  • 16. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
    He Y; Ren XJ; Hu BJ; Lam WC; Li XR
    BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
    Arıkan Yorgun M; Toklu Y; Mutlu M
    Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
    Kaldırım H; Savur F; Kırgız A; Atalay K
    Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Intravitreal Dexamethasone Treatment in Eyes with Pretreated Chronic Diabetic Macular Edema.
    Zandi S; Lereuil T; Freiberg F; Pfau M; Pfister IB; Gerhardt C; Michels S; Kodjikian L; Garweg JG
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):620-628. PubMed ID: 28836880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
    Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
    Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.